Literature DB >> 21656282

Treating rheumatoid arthritis to target: an international initiative.

Elana J Bernstein1, Jonathan Kay, Allan Gibofsky.   

Abstract

Entities:  

Year:  2011        PMID： 21656282      PMCID： PMC3261254          DOI： 10.1007/s12178-011-9082-y

Source DB:  PubMed          Journal:  Curr Rev Musculoskelet Med        ISSN： 1935-9748


× No keyword cloud information.
  8 in total

Review 1.  RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.

Authors:  Theodore Pincus; Yusuf Yazici; Martin J Bergman
Journal:  Rheum Dis Clin North Am       Date:  2009-11       Impact factor: 2.670

2.  Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008.

Authors:  Monika Schoels; Daniel Aletaha; Josef S Smolen; Johannes W J Bijlsma; Gerd Burmester; Ferdinand C Breedveld; Maurizio Cutolo; Bernard Combe; Maxime Dougados; Paul Emery; Joachim Kalden; Edward C Keystone; Tore K Kvien; Emilio Martin-Mola; Carlomaurizio Montecucco; Maarten De Wit
Journal:  Ann Rheum Dis       Date:  2009-04-22       Impact factor: 19.103

3.  Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.

Authors:  L H D van Tuyl; W F Lems; A E Voskuyl; P J S M Kerstens; P Garnero; B A C Dijkmans; M Boers
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

4.  Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

Authors:  Catriona Grigor; Hilary Capell; Anne Stirling; Alex D McMahon; Peter Lock; Ramsay Vallance; Wilma Kincaid; Duncan Porter
Journal:  Lancet       Date:  2004 Jul 17-23       Impact factor: 79.321

5.  Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).

Authors:  S M M Verstappen; J W G Jacobs; M J van der Veen; A H M Heurkens; Y Schenk; E J ter Borg; A A M Blaauw; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-05-22       Impact factor: 19.103

6.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2008-02

7.  Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors:  Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-03-09       Impact factor: 19.103

8.  Treating rheumatoid arthritis to target: the patient version of the international recommendations.

Authors:  M P T de Wit; J S Smolen; L Gossec; D M F M van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-04-07       Impact factor: 19.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.